Glenmark Pharmaceuticals (Razel) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Glenmark Pharmaceuticals (Razel) General Information

Description

Manufacturer of medicine intended for the treatment of cardiovascular disease. The company manufactures Rosuvastatin-based medicine and other combinations, thereby providing clients to prevent cardiovascular disease in those at high risk and treat abnormal lipids.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Mumbai
  • India
Primary Industry
Pharmaceuticals
Vertical(s)
Corporate Office
  • Mumbai
  • India

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Glenmark Pharmaceuticals (Razel) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Glenmark Pharmaceuticals (Razel)‘s full profile, request access.

Request a free trial

Glenmark Pharmaceuticals (Razel) Patents

Glenmark Pharmaceuticals (Razel) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-2958637-B1 Plate installation device, in particular fire protection plates Inactive 13-Apr-2010
FR-2958637-A1 Plates installation device for installation of e.g. fire protection plates on walls of tunnel, has manipulator arm whose compensating unit adapted to balance weight of gripping tool and plate according to vertical direction Active 13-Apr-2010
FR-2933718-A1 Method for making a bridge, in particular a mixed deck and formwork system suitable for implementing such a method Active 08-Jul-2008
FR-2933718-B1 Method for making a bridge, in particular a mixed deck and formwork system suitable for implementing such a method Active 08-Jul-2008
EP-2321463-A1 Shuttering method and system for producing a bridge Inactive 08-Jul-2008 E01D21/065
To view Glenmark Pharmaceuticals (Razel)’s complete patent history, request access »

Glenmark Pharmaceuticals (Razel) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Glenmark Pharmaceuticals (Razel)‘s full profile, request access.

Request a free trial

Glenmark Pharmaceuticals (Razel) FAQs

  • Where is Glenmark Pharmaceuticals (Razel) headquartered?

    Glenmark Pharmaceuticals (Razel) is headquartered in Mumbai, India.

  • What industry is Glenmark Pharmaceuticals (Razel) in?

    Glenmark Pharmaceuticals (Razel)’s primary industry is Pharmaceuticals.

  • Is Glenmark Pharmaceuticals (Razel) a private or public company?

    Glenmark Pharmaceuticals (Razel) is a Private company.

  • What is the current valuation of Glenmark Pharmaceuticals (Razel)?

    The current valuation of Glenmark Pharmaceuticals (Razel) is .

  • What is Glenmark Pharmaceuticals (Razel)’s current revenue?

    The current revenue for Glenmark Pharmaceuticals (Razel) is .

  • Who are Glenmark Pharmaceuticals (Razel)’s investors?

    Glenmark Pharmaceuticals has invested in Glenmark Pharmaceuticals (Razel).

  • When was Glenmark Pharmaceuticals (Razel) acquired?

    Glenmark Pharmaceuticals (Razel) was acquired on 22-Dec-2022.

  • Who acquired Glenmark Pharmaceuticals (Razel)?

    Glenmark Pharmaceuticals (Razel) was acquired by J. B. Chemicals & Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process